Navamedic ASA (OSL:NAVA)
Norway · Delayed Price · Currency is NOK 13.30
+0.60 (4.72%)
Oct 23, 2026, 4:25 PM CEST
Navamedic ASA Market Cap
Navamedic ASA has a market cap or net worth of 318.95 million as of October 23, 2026. It is the 32,934th most valuable company in the world and the 227th biggest in Norway. Its market cap has decreased by 41.92% in one year.
Market Cap
318.95M
Enterprise Value
449.00M
Revenue
574.31M
Global Rank
Country Rank
#227 Norway
PE Ratio
n/a
ChartMarket Cap Chart
Since March 31, 2006, Navamedic ASA's market cap has increased from 111.70M to 318.95M, an increase of 185.56%. That is a compound annual growth rate of 5.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 318.95M | -44.12% |
| Dec 30, 2025 | 570.76M | 25.74% |
| Dec 30, 2024 | 453.93M | -28.72% |
| Dec 29, 2023 | 636.85M | 5.92% |
| Dec 30, 2022 | 601.25M | 8.19% |
| Dec 30, 2021 | 555.75M | 90.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 5.49B |
| Circio Holding ASA | 3.16B |
| Nordhealth AS | 2.11B |
| Thor Medical ASA | 1.77B |
| INIFY Laboratories AB | 644.85M |
| Gentian Diagnostics ASA | 618.34M |
| Lytix Biopharma ASA | 612.12M |
| Zelluna ASA | 536.00M |